Ir a la página principal de las areastematicas de la SED
Recurso cientifico para profesionales
 
> Interacciones farmacol�gicas
Coordinado por:
Dr. Víctor Fernández Dueñas
 
 
Secciones
Generalidades
Noticias de prensa
Articulos originales
Revisiones
Libros
Revistas
Enlaces
Artículos comentados
 
 
Sitio creado por
Sociedad española del dolor (SED)

Portada Revisiones

OROS hydromorphone prolonged release: a review of its use in the management of chronic, moderate to severe pain. [ Sin clasificar ]( CNS Drugs. 2010 Apr;24(4):337-61. doi: 10.2165/11202580-000000000-00000.. )

Basic pharmacology of non-opioid analgesics. [ Sin clasificar ]( Nurs Stand. 2010 Mar 31-Apr 6;24(30):55-6, 58, 60-1. )

 
Recomienda este area

Si crees que este sitio puede interesar a algun compañero no dude en recomendarselo

Recomendar el sitio

 

Balancing analgesic efficacy with safety concerns in the older patient. [ Sin clasificar ]( Pain Manag Nurs. 2010 Jun;11(2 Suppl):S11-22. )

 

Treatment considerations for patients with neuropathic pain and other medical comorbidities. [ Sin clasificar ]( Mayo Clin Proc. 2010 Mar;85(3 Suppl):S15-25.. )

 

Differential impact of NSAIDs on rate of adverse events that require hospitalization in high-risk and general veteran populations: a retrospective cohort study. [ ]( Drugs Aging. 2010;27(1):63-71. doi: 10.2165/11531250-000000000-00000. )

 

Assessing efficacy of non-opioid analgesics in experimental pain models in healthy volunteers: an updated review. [ Sin clasificar ]( Br J Clin Pharmacol. 2009 Sep;68(3):322-41. )

 

Identifying and managing factors that interfere with or worsen blood pressure control. [ Sin clasificar ]( Postgrad Med. 2010 Mar;122(2):35-48. )

 

Treatment considerations for patients with neuropathic pain and other medical comorbidities. [ Sin clasificar ]( Mayo Clin Proc. 2010 Mar;85(3 Suppl):S15-25. )

 

Does aspirin use adversely influence intermediate-term postdischarge outcomes for hospitalized patients who are treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers? [ ]( Am Heart J. 2010 Feb;159(2):222-230.e2. )

 

Drug interactions in dentistry. [ Sin clasificar ]( Dent Update. 2009 Oct;36(8):458-60, 463-6, 469-70. )